Table 2.
Plasma lipid and lipoprotein changes upon alteration in the expression of the LIGHT/lymphotoxin co-stimulatory family in female Ldlr−/− mice fed a western-type diet for 12 weeks. All differences are relative to control Ldlr−/− mice.
| LIGHT/Lymphotoxin family models | Site of expression/deficiency | Plasma lipid effects | Lipoprotein effects |
|---|---|---|---|
| Transgene | |||
| LIGHT | T cell | ↑ | ↑ HDL1 |
| Deficiency | |||
| LIGHT | Global | ↓ | ↓ VLDL, LDL, HDL |
| Ltα | Global | ↓ | ↓ VLDL, LDL |
| Ltβ | T cell | ↓ | ↓ VLDL, LDL |
| HVEM | Global | ↓ | ↓ VLDL, LDL, HDL |
| LTβR | Global | – | |
HDL: High-density lipoprotein; HVEM: Herpes virus entry mediator; LDL: Low-density lipoprotein; Ldlr−/−: LDL receptor deficient; Lt: Lymphotoxin; LTβR: Lymphotoxin β receptor; VLDL: Very low density lipoprotein.
Data from [A Reardon & GS Getz, Unpublished Data].